Immunologists at UNIGE have revealed a previously unknown anti-tumor role of CD4 T lymphocytes, marking a breakthrough that ...

A new study, published recently in Nature Communications, offers the first-ever map of which parts of Chikungunya virus ...

Immune checkpoint pathways regulate T cell function and play pivotal roles in the treatment of both cancer and autoimmune ...

Scientists say they have very strong evidence that the adult human brain is capable of making new neurons, a point of ongoing controversy in neuroscience.

A new study, published recently in Nature Communications, offers the first-ever map of which parts of the Chikungunya virus ...

The team suspects that neurogenesis happens in other parts of the adult brain, too. In mice, new neurons are regularly made ...

Cancer-fighting T-cells, the immune system's primary enforcers, are scarce in the rare kidney cancer called chromophobe renal ...

During animal development, cells divide and arrange themselves in a coordinated way, eventually forming the embryo. The cells ...

As part of the deal, AbbVie will acquire Capstan's targeted LNP platform technology and its lead candidate for B cell-mediated autoimmune diseases.

Thymic crosstalk between T cells and the thymus during T-cell priming shapes how the thymus grows and shapes itself.

Under terms of the deal, AbbVie will acquire Capstan’s lead asset, CPTX2309—an in vivo anti-CD19 CAR T-cell therapy in Phase ...

AbbVie (NYSE: ABBV) and Capstan Therapeutics, Inc. ("Capstan"), a clinical-stage biotechnology company dedicated to advancing in vivo engineering of cells through RNA delivery using tLNPs, today ...